BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37094771)

  • 1. Incidence and Risk Factors for Radiotherapy-Induced Oral Mucositis Among Patients With Nasopharyngeal Carcinoma: A Meta-Analysis.
    Li J; Zhu C; Zhang Y; Guan C; Wang Q; Ding Y; Hu X
    Asian Nurs Res (Korean Soc Nurs Sci); 2023 May; 17(2):70-82. PubMed ID: 37094771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting Nomogram for Severe Oral Mucositis in Patients with Nasopharyngeal Carcinoma during Intensity-Modulated Radiation Therapy: A Retrospective Cohort Study.
    Liu Z; Huang L; Wang H; Shi Z; Huang Y; Liang L; Wang R; Hu K
    Curr Oncol; 2022 Dec; 30(1):219-232. PubMed ID: 36661666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scheduling radiotherapy for patients with nasopharyngeal carcinoma in the corresponding time window can reduce radiation-induced oral mucositis: A randomized, prospective study.
    Lv J; Liao S; Li B; Pan L; Wang R
    Cancer Med; 2023 Aug; 12(15):16032-16040. PubMed ID: 37537945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive microbiota of delayed healing of oral mucositis after radiotherapy of nasopharyngeal carcinoma.
    Jiang R; Liu Y; Zhang H; Chen Y; Liu T; Zeng J; Nie E; Chen S; Tan J
    Front Cell Infect Microbiol; 2022; 12():1070322. PubMed ID: 36605128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of thalidomide in preventing oral mucositis in patients with nasopharyngeal carcinoma undergoing concurrent chemoradiotherapy: A multicenter, open-label, randomized controlled trial.
    Liang L; Liu Z; Zhu H; Wang H; Wei Y; Ning X; Shi Z; Jiang L; Lin Z; Yan H; Wang R; Hu K
    Cancer; 2022 Apr; 128(7):1467-1474. PubMed ID: 34910297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Potential Effect of Oral Microbiota in the Prediction of Mucositis During Radiotherapy for Nasopharyngeal Carcinoma.
    Zhu XX; Yang XJ; Chao YL; Zheng HM; Sheng HF; Liu HY; He Y; Zhou HW
    EBioMedicine; 2017 Apr; 18():23-31. PubMed ID: 28216066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of recombinant human granulocyte colony-stimulating factor mouthwash on radiotherapy-induced oral mucositis in locally advanced nasopharyngeal carcinoma patients.
    Liang G; Du W; Ke Q; Huang B; Yang J
    Adv Clin Exp Med; 2017; 26(3):409-413. PubMed ID: 28791814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herb medicine for relieving radiation induced oral mucositis: A systematic review and meta-analysis protocol.
    Wang G; Jia L
    Medicine (Baltimore); 2019 Dec; 98(50):e18337. PubMed ID: 31852129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical application of honey in the management of chemo/radiotherapy-induced oral mucositis: A systematic review and network meta-analysis.
    Yang C; Gong G; Jin E; Han X; Zhuo Y; Yang S; Song B; Zhang Y; Piao C
    Int J Nurs Stud; 2019 Jan; 89():80-87. PubMed ID: 30352321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Propolis mouthwash for preventing radiotherapy-induced mucositis in patients with nasopharyngeal carcinoma.
    Hamzah MH; Mohamad I; Musa MY; Abd Mutalib NS; Siti-Azrin AH; Wan Omar WA
    Med J Malaysia; 2022 Jul; 77(4):462-467. PubMed ID: 35902936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute oral mucositis in nasopharyngeal carcinoma patients treated with radiotherapy: association with genetic polymorphism in DNA DSB repair genes.
    Ren JH; Dai XF; Yan GL; Jin M; Liu CW; Yang KY; Wu G; Ma CM
    Int J Radiat Biol; 2014 Mar; 90(3):256-61. PubMed ID: 24350917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Chen G; Jiang H; Jiang D; Wu Q; Li Z; Hua X; Hu X; Zhao H; Wang X; Yu H; Xie C; Zhong Y
    Head Neck; 2021 Apr; 43(4):1153-1160. PubMed ID: 33300654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2007 Oct; (4):CD000978. PubMed ID: 17943748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for preventing oral mucositis for patients with cancer receiving treatment.
    Worthington HV; Clarkson JE; Eden OB
    Cochrane Database Syst Rev; 2006 Apr; (2):CD000978. PubMed ID: 16625538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, controlled phase II trial of maxillofacial and oral massage in attenuating severe radiotherapy-induced oral mucositis and lipid metabolite changes in nasopharyngeal carcinoma.
    Yang G; Feng D; Li F; Luo B; Zhu J; Yang Q; Zheng L; Dong Q; Chen M; Xu Z; Li L; Chen P; Sun J
    Radiother Oncol; 2021 Oct; 163():76-82. PubMed ID: 34343545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of oral mucositis risk factors during radiotherapy for nasopharyngeal carcinoma patients and establishment of a discriminant model].
    Luo DH; Hong MH; Guo L; Cao KJ; Deng MQ; Mo HY
    Ai Zheng; 2005 Jul; 24(7):850-4. PubMed ID: 16004814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients.
    Li H; You Y; Lin C; Zheng M; Hong C; Chen J; Li D; Au WW; Chen Z
    Radiat Oncol; 2013 Feb; 8():31. PubMed ID: 23375119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Chinese Patent Medicine for the Prevention and Treatment of Radiotherapy and Chemotherapy-Induced Oral Mucositis: A Systematic Review and Meta-Analysis.
    Xie Y; Fang X; Hua H; Zhou P
    Front Pharmacol; 2022; 13():812085. PubMed ID: 35418855
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of the efficacy of the anti-ulcer oral mucosal protective agent RADoralex® in the prevention and treatment of radiation-induced oral mucosal reactions induced during treatment of nasopharyngeal carcinoma.
    Yin J; Xie J; Lin J; Weng C; Lu S; Xu P; Zhang S; Luo C; Huang Y; Li L; Lang J; Feng M
    Cancer Biol Ther; 2022 Dec; 23(1):27-33. PubMed ID: 34989325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.